EURETINA Innovation Spotlight (EIS)
Wednesday 3 September 2025
Le Palais des Congrès, Paris
EIS Organising Committee
Prof. Anat Loewenstein
President
EURETINA
Dr. Kourous Rezaei
Co-opted Board Member
EURETINA
PROF. Martin Zinkernagel
General Secretary
EURETINA
Prof. Nicole Eter
PRESIDENT ELECT
EURETINA
Mr. Alistair Laidlaw
Past President
EURETINA
DARA CONLON
EXECUTIVE VICE-PRESIDENT
EURETINA
Contributors
Euretina is delighted to announce the following speakers and panellists confirmed to participate in the EURETINA Innovation Spotlight (EIS) taking place on the 3rd September 2025 at the Palais des Congrès in Paris, preceding the EURETINA Annual Congress.
Kfir Azoulay
Managing Director
HEIDELBERG ENGINEERING
Dr. Sam Barone
CMO
NANOSCOPE THERAPEUTICS
Caroline Baumal, MD
Chief Medical Officer
OCULIS
Prof. Francesco Bandello
University Vita-Salute Ospedale San Raffaele
ITALY
Mr. Pierre Billardon
CEO, DORC / Head of Business Sectors Surgery Posterior Segment, Zeiss
DORC / ZEISS MEDICAL TECHNOLOGY
Prof. Bart Leroy
BELGIUM
Jedd Comiskey
Head of Europe
OUTLOOK THERAPEUTICS
Dhaval Desai
Chief Development Officer
4DMT
Brad Doerschuk
PRESIDENT & CEO
INFOCUS CLINICAL RESEARCH
Anders Haegerstrand
CEO
ANNEXIN PHARMACEUTICAL
Juho Himberg
CEO
OPTOMED
Prof. Frank Holz
GERMANY
Ralf Hornig, PhD
Clinical Affairs Director
SCIENCE CORPORATION
Scott Jones
Chief Commercial Officer
EYEPOINT PHARMACEUTICALS
Peter Kaiser, MD
Chief Development Officer
OCULAR THERAPEUTIX
Prof. Caroline Klaver
THE NETHERLANDS
MS. Anne Marie Cairns
Chief Clinical Officer
OPTOS
Jane Moseley
Dr. Huma Qamar, MD
Chief Medical Officer
OCUGEN
Michael O'Rourke
RE-VANA THERAPEUTICS
Georgy Shakirin
Head of Artificial Intelligence
CARL ZEISS
DR. Riad Sherif
CEO
OCULIS
Rich Small
CEO
NEUROTECH
Charles Wykof, MD, PhD
Director of Research, Retina Consultants of Texas
Additional Contributors:
| Dimitris Aktypis, Alcon |
| Muhammad Ali Memon, Complement Therapeutics |
| Peter Francis, Ray Therapeutics |
| Wesley Jackson, Valitor |
| Luis Lesmes, Adaptive Sensory Technology |
| Natalia Misciattelli, AAVantgarde |
| Sumie Takahara, RegenxBio |
| Morgane Rousselot, SeaBeLife Biotech |